Files in this Data Supplement:

• Appendix Table 1 - Individual Studies Included in Systematic Reviews
• Appendix Table 2 - Designs of the Modeled Analyses of the Costs of Using Low-Molecular-Weight Heparin Compared with Unfractionated Heparin for Treatment of Venous Thromboembolism
• Appendix Table 3. - Results of the Modeled Analyses of the Costs of Using Low-Molecular-Weight Heparin Compared with Unfractionated Heparin for Treatment of Venous Thromboembolism